1185 studies found for:    "Macular Degeneration"
Show Display Options
Rank Status Study
1 Completed Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments
Conditions: Age-related Macular Degeneration;   Pigment Epithelial Detachment;   Neovascular Macular Degeneration;   Wet Macular Degeneration
Intervention: Drug: ranibizumab
2 Unknown  HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
Conditions: Wet Macular Degeneration;   Macular Degeneration;   Pigment Epithelium of Eye;   Retinal Detachment
Intervention: Drug: ranibizumab
3 Unknown  Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Conditions: Age-Related Macular Degeneration;   Wet Age-Related Macular Degeneration;   Macular Degeneration;   Eye Diseases;   Retinal Diseases
Intervention: Device: IRay
4 Terminated
Has Results
The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration
Conditions: Choroidal Neo-Vascular Age-onset Macular Degeneration;   Age-related Macular Degeneration
Interventions: Drug: Everolimus;   Drug: Ranibizumab
5 Completed Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
Conditions: Neovascular Age-elated Macular Degeneration (Wet AMD);   Exudative Macular Degeneration
Interventions: Drug: LFG316;   Drug: Placebo
6 Completed Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)
Conditions: Age Related Macular Degeneration;   Macular Degeneration;   AMD
Intervention: Drug: HuCNS-SC cells
7 Completed Dorzolamide-timolol Eye Drops Given With Eye Injections to Treat Age-related Macular Degeneration
Conditions: Wet Macular Degeneration;   Age-related Macular Degeneration
Intervention: Drug: Dorzolamide-timolol
8 Active, not recruiting Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Macular Degeneration
Interventions: Drug: Intravitreal Aflibercept Injection More;   Drug: Intravitreal Aflibercept Injection Less
9 Completed
Has Results
Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration
Conditions: Macular Degeneration;   Age-related Macular Degeneration;   Neovascular Macular Degeneration
Intervention: Drug: Pegaptanib
10 Recruiting An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Wet Macular Degeneration;   Macular Degeneration;   Eye Diseases;   Retinal Diseases
Intervention: Device: IRay
11 Completed Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: pazopanib eye drops;   Drug: placebo;   Biological: ranibizumab intravitreal injection
12 Active, not recruiting Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration
Conditions: Macular Degeneration;   Age-related Maculopathies;   Age-related Maculopathy;   Maculopathies,Age-related;   Maculopathy,Age-related;   Retinal Degeneration;   Retinal Neovascularization;   Eye Diseases
Interventions: Biological: rAAV.sFlt-1;   Other: Control (ranibizumab alone)
13 Recruiting OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab
Condition: Wet Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: OZURDEX
14 Withdrawn Combination Therapy for Neovascular Age Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: intravitreal bevacizumab and triamcinolone acetonide
15 Withdrawn Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)
Conditions: Wet Age-related Macular Degeneration;   Age-related Macular Degeneration;   AMD;   Wet AMD;   Macular Degeneration
Intervention: Device: IRay
16 Unknown  Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab
Condition: Wet Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide
17 Unknown  Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Microplasmin;   Drug: Placebo control
18 Completed Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Drug: pegaptanib sodium
19 Unknown  Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Interventions: Drug: ORA102 and Avastin;   Drug: Avastin
20 Recruiting Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration
Condition: Age-related Macular Degeneration
Intervention: Drug: Ranibizumab 0.5mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years